Petros Pharmaceuticals, Inc. — Form D
Petros Pharmaceuticals, Inc. of NEW YORK, NY, a company, filed a Form D exempt-offering notice with the SEC on 2023-07-21. The offering totals $30.0M, of which $30.0M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2023-07-21
- Form: D
- Accession: 0001104659-23-083066
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $30.0M
- Amount sold: $30.0M
- Investors: 15
- Date of first sale: 2023-07-13
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-487617
Issuer
- Name: Petros Pharmaceuticals, Inc.
- CIK: 0001815903
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2020
- Address: 1185 AVENUE OF THE AMERICAS, NEW YORK, NY, 10036
- Phone: 973-242-0005
Officers, directors & promoters (8)
| Name | Role | Location |
|---|
| BRUCE T BERNSTEIN | Director | NEW YORK, NY |
| Gregory T Bradley | Director | New York, NY |
| John D Shulman | Director | New York, NY |
| Joshua N Silverman | Director | LAS VEGAS, NV |
| Wayne R Walker | Director | Round Rock, TX |
| Mitchell Arnold | Executive Officer | New York, NY |
| Fady Boctor | Executive Officer | New York, NY |
| Andrew R Gesek | Executive Officer | New York, NY |
Other filings by this issuer (3)
More